Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function

Erik J.M. van Bommel; Yuliya Lytvyn; Bruce A. Perkins; Nima Soleymanlou; Nora M. Fagan; Audrey Koitka-Weber; Jaap A. Joles; David Z.I. Cherney; Daniël H. van Raalte

doi:10.1016/j.kint.2019.12.021

Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function

Erik J.M. van Bommel^*, Yuliya Lytvyn, Bruce A. Perkins, Nima Soleymanlou, Nora M. Fagan, Audrey Koitka-Weber, Jaap A. Joles, David Z.I. Cherney, Daniël H. van Raalte

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	631-635
Number of pages	5
Journal	Kidney International
Volume	97
Issue number	4
DOIs	https://doi.org/10.1016/j.kint.2019.12.021
Publication status	Published - Apr 2020

Access to Document

10.1016/j.kint.2019.12.021

Link to publication in Scopus

Cite this

van Bommel, E. J. M., Lytvyn, Y., Perkins, B. A., Soleymanlou, N., Fagan, N. M., Koitka-Weber, A., Joles, J. A., Cherney, D. Z. I., & van Raalte, D. H. (2020). Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function. Kidney International, 97(4), 631-635. https://doi.org/10.1016/j.kint.2019.12.021

van Bommel, Erik J.M. ; Lytvyn, Yuliya ; Perkins, Bruce A. ; Soleymanlou, Nima ; Fagan, Nora M. ; Koitka-Weber, Audrey ; Joles, Jaap A. ; Cherney, David Z.I. ; van Raalte, Daniël H. / Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function. In: Kidney International. 2020 ; Vol. 97, No. 4. pp. 631-635.

@article{054240d62d8a4458a79a76a14052825e,

title = "Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function",

keywords = "diabetes, diabetic nephropathy, glomerular hyperfiltration, SGLT2 inhibition",

author = "{van Bommel}, {Erik J.M.} and Yuliya Lytvyn and Perkins, {Bruce A.} and Nima Soleymanlou and Fagan, {Nora M.} and Audrey Koitka-Weber and Joles, {Jaap A.} and Cherney, {David Z.I.} and {van Raalte}, {Dani{\"e}l H.}",

year = "2020",

month = apr,

doi = "10.1016/j.kint.2019.12.021",

language = "English",

volume = "97",

pages = "631--635",

journal = "Kidney International",

issn = "0085-2538",

publisher = "Nature Publishing Group",

number = "4",

}

van Bommel, EJM, Lytvyn, Y, Perkins, BA, Soleymanlou, N, Fagan, NM, Koitka-Weber, A, Joles, JA, Cherney, DZI & van Raalte, DH 2020, 'Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function', Kidney International, vol. 97, no. 4, pp. 631-635. https://doi.org/10.1016/j.kint.2019.12.021

Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function. / van Bommel, Erik J.M.; Lytvyn, Yuliya; Perkins, Bruce A.; Soleymanlou, Nima; Fagan, Nora M.; Koitka-Weber, Audrey; Joles, Jaap A.; Cherney, David Z.I.; van Raalte, Daniël H.

In: Kidney International, Vol. 97, No. 4, 04.2020, p. 631-635.

Research output: Contribution to journal › Editorial › Academic › peer-review

TY - JOUR

T1 - Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function

AU - van Bommel, Erik J.M.

AU - Lytvyn, Yuliya

AU - Perkins, Bruce A.

AU - Soleymanlou, Nima

AU - Fagan, Nora M.

AU - Koitka-Weber, Audrey

AU - Joles, Jaap A.

AU - Cherney, David Z.I.

AU - van Raalte, Daniël H.

PY - 2020/4

Y1 - 2020/4

KW - diabetes

KW - diabetic nephropathy

KW - glomerular hyperfiltration

KW - SGLT2 inhibition

UR - http://www.scopus.com/inward/record.url?scp=85081202146&partnerID=8YFLogxK

U2 - 10.1016/j.kint.2019.12.021

DO - 10.1016/j.kint.2019.12.021

M3 - Editorial

C2 - 32200854

AN - SCOPUS:85081202146

VL - 97

SP - 631

EP - 635

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 4

ER -